Eli Lilly brings monthly Alzheimer's therapy donanemab to India at ₹91,688 per vial

Eli Lilly is making Alzheimer's a major focus for its future innovations. The company is also expanding its specialty medicine offerings in India. Eli Lilly has launched Lormalzi, a new monthly treatment for early Alzheimer's disease. This drug targets amyloid plaques. It will be available in India this month. The treatment costs 91,688 rupees per vial.